tiprankstipranks
Trending News
More News >
Novartis AG (CH:NOVN)
:NOVN

Compare Novartis AG (NOVN) vs. Competitors

Compare
38 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Novartis AG
CHF115.60
CHF217.88B
18.35
27.61%
7 Buy
4 Hold
0 Sell
Moderate Buy
Roche Holding AG
CHF348.90
CHF276.02B
29.18
29.90%
5 Buy
4 Hold
2 Sell
Moderate Buy
Lonza Group Ltd
CHF559.20
CHF38.55B
53.24
2.08%
3 Buy
0 Hold
0 Sell
Strong Buy
Alcon
CHF63.96
CHF31.85B
35.07
-16.33%
6 Buy
4 Hold
1 Sell
Moderate Buy
Galderma Group AG
CHF159.10
CHF37.06B
114.21
45.51%
7 Buy
2 Hold
0 Sell
Strong Buy
Roche Holding Ltd
CHF335.20
CHF276.02B
29.76
23.92%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:NOVN
Novartis AG
115.60
29.45
34.18%
CH:ROG
Roche Holding AG
348.90
90.54
35.05%
CH:LONN
Lonza Group Ltd
559.20
-0.09
-0.02%
CH:ALC
Alcon
63.96
-13.75
-17.69%
CH:GALD
Galderma Group AG
159.10
53.20
50.24%
CH:RO
Roche Holding Ltd
356.40
79.62
28.77%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts